Simultaneous quantitative determination of the HIV protease inhibitors amprenavir, indinavir, nelfinavir, ritonavir and saquinavir in human plasma by ion-pair high-performance liquid chromatography with ultraviolet detection
- 1 November 1998
- journal article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 719 (1-2), 159-168
- https://doi.org/10.1016/s0378-4347(98)00392-2
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Resistance and cross-resistance with saquinavir and other HIV protease inhibitorsAIDS, 1998
- The role of combinations of HIV protease inhibitors in the management of persons with HIV infectionExpert Opinion on Investigational Drugs, 1998
- High-performance liquid chromatographic determination of ritonavir in human plasma, cerebrospinal fluid and salivaJournal of Chromatography B: Biomedical Sciences and Applications, 1998
- Saquinavir pharmacokinetics alone and in combination with nelfinavir in HIV-infected patientsAIDS, 1997
- Toxicity, efficacy, plasma drug concentrations and protease mutations in patients with advanced HIV infection treated with ritonavir plus saquinavirAIDS, 1997
- Determination of saquinavir in human plasma, saliva, and cerebrospinal fluid by ion-pair high-performance liquid chromatography with ultraviolet detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1997
- Saquinavir pharmacokinetics alone and in combination with ritonavir in HIV-infected patientsAIDS, 1997
- Clinical pharmacology of HIV protease inhibitors: focus on saquinavir, indinavir, and ritonavirInternational Journal of Clinical Pharmacy, 1997
- Quantification of the anti‐HIV drug saquinavir by high‐speed on‐line high‐performance liquid chromatography/tandem mass spectrometryJournal of Mass Spectrometry, 1995
- Calibration and validation of linearity in chromatographic biopharmaceutical analysisJournal of Pharmaceutical and Biomedical Analysis, 1991